Drug
Sel 110
Sel 110: highest development phase Phase 1, developed by Selecta Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Selecta Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| SEL-110 NCT02648269 | Phase 1 | Gout |
Latest
No recent events.
Follow Sel 110 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.